LGT Financial Advisors »

United Therapeutics Corporation shares owned by LGT Financial Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by LGT Financial Advisors from 13F filings

Historical chart of LGT Financial Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by LGT Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by LGT Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $33k 93 352.84
2024-09-30 $33k 93 358.35
2024-06-30 $30k 93 318.55
2024-03-31 $21k 93 229.72
2023-12-31 $21k 93 219.89
2023-09-30 $21k 93 225.87

More positions owned by LGT Financial Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Chevron Corporation (CVX)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Msci Usa Qlt Fct (QUAL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Exxon Mobil Corporation (XOM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 3000 Etf (IWV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)

View all positions for LGT Financial Advisors

Top funds holding United Therapeutics Corporation

Wealthfront Advisers
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
State Street Corporation
Renaissance Technologies
FMR
Geode Capital Management
AQR Capital Management
LSV Asset Management
Alliancebernstein
Dimensional Fund Advisors
Pacer Advisors
Arrowstreet Capital, Limited Partnership

View all funds holding United Therapeutics Corporation